Litigation Details for Hospira, Inc. v. Fresenius Kabi USA, LLC (N.D. Ill. 2017)
✉ Email this page to a colleague
Hospira, Inc. v. Fresenius Kabi USA, LLC (N.D. Ill. 2017)
Docket | ⤷ Try a Trial | Date Filed | 2017-11-01 |
Court | District Court, N.D. Illinois | Date Terminated | 2018-12-16 |
Cause | 35:271 Patent Infringement | Assigned To | Rebecca R. Pallmeyer |
Jury Demand | None | Referred To | |
Patents | 6,011,007; 8,242,158; 8,338,470; 8,455,527; 8,648,106; 9,320,712; 9,616,049 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Hospira, Inc. v. Fresenius Kabi USA, LLC
Biologic Drugs cited in Hospira, Inc. v. Fresenius Kabi USA, LLC
Details for Hospira, Inc. v. Fresenius Kabi USA, LLC (N.D. Ill. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-11-01 | 1 | infringement of U.S. Patent No. 9,616,049 (the “’049 patent”) (Ex. A) (the “Patent-in-suit”). … COUNT I FOR INFRINGEMENT OF PATENT NO. 9,616,049 17. Paragraphs 1 through… THE PATENT-IN-SUIT 9. The ’049 patent, entitled “Dexmedetomidine…assignee and owner of the ’049 patent. 10. The Patent-in-suit is duly listed in the… 4. This action is based upon the Patent Laws of the United States, 35 U.S.C. § 1 et seq | External link to document | |
2018-12-17 | 109 | Order on Motion for Partial Summary Judgment | :4-16, 414:6-11.) (See id. at 413:4-9, 414:6-11.) 7 In response, Dr. Kipp explained why he believes…8,242,158 (the “’158 Patent”), 8,338,470 (the “’470 Patent”), 8,455,527 (the “’527 Patent”), and 8,648,106 (the…product—U.S. Patent No. 9,616,049 (the “’049 Patent”)—and filed a second complaint of patent infringement…obtained a patent that disclosed and claimed the compound: U.S. Patent No. 4,910,214 (the “’214 Patent”), JTX…named co- inventors of the patents-in-suit. (See ’106 Patent, JTX 1; ’049 Patent, JTX 2.) Dr. Roychowdhury | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |